This result indicates that EAPB02303 exhibits similar molecular activity on the SENP3/NPM1/ARF pathway as its parental compound, EAPB0503, in NPM1c AML cells, but at 200-fold lower concentrations [29]. This evidence concerns the gene CDKN2A and acute myeloid leukemia.